These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26 related articles for article (PubMed ID: 19948948)
1. Pharmacokinetics of Ambroxol Sustained Release (Mucosolvan Ollier C; Sent U; Mesquita M; Michel MC Pulm Ther; 2020 Jun; 6(1):119-130. PubMed ID: 32372294 [TBL] [Abstract][Full Text] [Related]
2. Once-daily Extended-Release Pemafibrate Enhances Adherence and Triglyceride Control Over Twice-Daily Dosing. Akasaki Y J Atheroscler Thromb; 2024 Jun; ():. PubMed ID: 38925925 [No Abstract] [Full Text] [Related]
3. Trospium chloride and oxybutynin hydrochloride in a german study of adults with urinary urge incontinence: results of a 12-week, multicenter, randomized, double-blind, parallel-group, flexible-dose noninferiority trial. Zellner M; Madersbacher H; Palmtag H; Stöhrer M; Bödeker RH; Clin Ther; 2009 Nov; 31(11):2519-39. PubMed ID: 20109997 [TBL] [Abstract][Full Text] [Related]
4. Comparative Effectiveness of Anticholinergic Agents for Lower Urinary Tract Symptoms. Goodson AB; Cantrell MA; Shaw RF; Lund BC J Manag Care Spec Pharm; 2018 Jan; 24(1):65-72. PubMed ID: 29290176 [TBL] [Abstract][Full Text] [Related]
5. Treatment of Overactive Bladder in the Elderly Female: The Case for Trospium, Oxybutynin, Fesoterodine and Darifenacin. McFerren SC; Gomelsky A Drugs Aging; 2015 Oct; 32(10):809-19. PubMed ID: 26391900 [TBL] [Abstract][Full Text] [Related]
6. Effect of concomitant administration of trospium chloride extended release on the steady-state pharmacokinetics of metformin in healthy adults. Oefelein MG; Tong W; Kerr S; Bhasi K; Patel RK; Yu D Clin Drug Investig; 2013 Feb; 33(2):123-31. PubMed ID: 23325481 [TBL] [Abstract][Full Text] [Related]
7. [Trospium chloride once daily for overactive bladder syndrome: results of a multicenter observational study]. Notz HJ; Hautumm B; Werdier D; Groves R; Odenthal KP Urologe A; 2013 Jan; 52(1):65-70. PubMed ID: 23052979 [TBL] [Abstract][Full Text] [Related]
11. Once daily trospium chloride is effective and well tolerated for the treatment of overactive bladder: results from a multicenter phase III trial. Staskin D; Sand P; Zinner N; Dmochowski R; J Urol; 2007 Sep; 178(3 Pt 1):978-83; discussion 983-4. PubMed ID: 17632131 [TBL] [Abstract][Full Text] [Related]
12. Once-daily administration of trospium chloride extended release provides 24-hr coverage of nocturnal and diurnal symptoms of overactive bladder: an integrated analysis of two phase III trials. Ginsberg DA; Oefelein MG; Ellsworth PI Neurourol Urodyn; 2011 Apr; 30(4):563-7. PubMed ID: 21268101 [TBL] [Abstract][Full Text] [Related]
13. Study of the population pharmacokinetic characteristics of once-daily trospium chloride 60 mg extended-release capsules in patients with overactive bladder and in healthy subjects. Harnett MD; Shipley J; MacLean L; Schwiderski U; Sandage BW Clin Drug Investig; 2013 Feb; 33(2):133-41. PubMed ID: 23203138 [TBL] [Abstract][Full Text] [Related]
14. Steady-state pharmacokinetics of once-daily cyclobenzaprine extended release: a randomized, double-blind, 2-period crossover study in healthy volunteers. Darwish M; Hellriegel ET Clin Ther; 2011 Jun; 33(6):746-53. PubMed ID: 21704239 [TBL] [Abstract][Full Text] [Related]